Nicholas Glover - 15 Jul 2025 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Nicholas Glover
Issuer symbol
MEIP
Transactions as of
15 Jul 2025
Net transactions value
$0
Form type
4
Filing time
17 Jul 2025, 21:38:02 UTC
Previous filing
12 Oct 2023
Next filing
19 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glover Nicholas Director C/O MEI PHARMA, INC., 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO /s/ Nicholas Glover 17 Jul 2025 0001578888

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 15 Jul 2025 Common Stock 20,000 $3.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.